OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
16
Results
Show all
Save search
Copy query
Show results for
Unknown
(16)
Publication Date
Release Date
2022
(4)
2021
(4)
2025
(3)
2023
(3)
2019
(1)
2018
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Simplifying The Medicare Plan Finder Tool Could Help Older Adults Choose Lower-Cost Part D Plans.
Not available
S-EPMC6417418
|
biostudies-literature
Cite
Larger Nursing Home Staff Size Linked To Higher Number Of COVID-19 Cases In 2020.
Not available
S-EPMC8616631
|
biostudies-literature
Cite
A genome-wide association and admixture mapping study of bronchodilator drug response in African Americans with asthma.
Not available
S-EPMC6414286
|
biostudies-literature
Cite
Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19: The RECOVERY-RS Randomized Clinical Trial.
Not available
S-EPMC8787685
|
biostudies-literature
Cite
Safety, Immunogenicity, and Efficacy of the NVX-CoV2373 COVID-19 Vaccine in Adolescents: A Randomized Clinical Trial.
Not available
S-EPMC10536880
|
biostudies-literature
Cite
Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
Not available
S-EPMC8491132
|
biostudies-literature
Cite
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.
Not available
S-EPMC11869088
|
biostudies-literature
Cite
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.
Not available
S-EPMC12303861
|
biostudies-literature
Cite
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
Not available
S-EPMC8121538
|
biostudies-literature
Cite
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets